Nivolumab

Strength: 40 mg/mL

Dosage Form: Injection solution

Description:

Nivolumab is a PD-1 immune checkpoint inhibitor that boosts the immune system to fight cancer cells. It’s used in melanoma, lung cancer, renal cell carcinoma, and others.

Key Features:

• Immune checkpoint blockade therapy
• Often used after other treatments fail
• IV administration

Precautions:

Watch for immune-mediated side effects. Monitor for pneumonitis and hepatitis.